Glenn Dubin is Director at C4 Therapeutics, Inc. (CCCC). They have made 7 open-market trades across 3 companies since 2010, most recently 2024-04-01.
CIK 0001308597
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PrivateASGI Corbin Multi-Strategy Fund, LLC | SELL | 2012-06-30 | 2012-07-02 | $102.67 | $2.1M | N/A | N/A | N/A |
| PrivateASGI Corbin Multi-Strategy Fund, LLC | SELL | 2012-03-30 | 2012-04-02 | $101.18 | $2.5M | N/A | N/A | N/A |
| PrivateASGI Corbin Multi-Strategy Fund, LLC | SELL | 2011-12-31 | 2012-01-03 | $99.63 | $6.3M | N/A | N/A | N/A |
| AMIE | SELL | 2011-01-13 | 2011-01-18 | $1.39 | $97K | N/A | N/A | N/A |
| AMIE | SELL | 2010-07-29 | 2010-08-02 | $0.48 | $14K | N/A | N/A | N/A |
| AMIE | SELL | 2010-06-10 | 2010-06-14 | $0.51 | $1K | N/A | N/A | N/A |
| GDMN | SELL | 2010-03-19 | 2010-03-23 | $8.50 | $3.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.